Hood River Capital Management LLC
Institutional investor · Portfolio as of Q1 2019
Top Holdings105 positions
BIOTELEMETRY INC | 954,906 | $59.8M | 3.0% | — | — | 1 qtr | First report 0 |
| 1.3M | $59.6M | 3.0% | — | — | — | First report 0 | |
SAGE THERAPEUTICS INC | 350,368 | $55.7M | 2.8% | — | — | 1 qtr | First report 0 |
CHART INDS INC | 528,457 | $47.8M | 2.4% | $90.52 | 0.00% | 1 qtr | First report 0 |
CHARLES RIV LABS INTL INC | 326,175 | $47.4M | 2.4% | $145.25 | 0.00% | 1 qtr | First report 0 |
| 511,603 | $44.3M | 2.2% | — | — | 1 qtr | First report 0 | |
AMARIN CORP PLC | 2.1M | $42.7M | 2.1% | — | — | — | First report 0 |
GLOBANT S A | 567,843 | $40.5M | 2.0% | $71.40 | 0.00% | 1 qtr | First report 0 |
MASTEC INC COM | 834,245 | $40.1M | 2.0% | $48.10 | 0.00% | 1 qtr | First report 0 |
WELLCARE HEALTH PLANS INC | 146,222 | $39.4M | 2.0% | — | — | 1 qtr | First report 0 |
FIVE9 INC | 731,141 | $38.6M | 1.9% | $52.83 | 0.00% | 1 qtr | First report 0 |
TPI COMPOSITES INC | 1.3M | $37.7M | 1.9% | $28.62 | 0.00% | 1 qtr | First report 0 |
CHEGG INC | 946,986 | $36.1M | 1.8% | $38.12 | 0.00% | 1 qtr | First report 0 |
KINSALE CAP GROUP INC | 525,317 | $36M | 1.8% | $67.63 | 0.00% | 1 qtr | First report 0 |
CONMED CORP COM | 432,012 | $35.9M | 1.8% | $78.42 | 0.00% | 1 qtr | First report 0 |
GRAND CANYON ED INC | 313,007 | $35.8M | 1.8% | $114.51 | 0.00% | 1 qtr | First report 0 |
COSTAR GROUP INC | 75,016 | $35M | 1.8% | $46.64 | 0.00% | 1 qtr | First report 0 |
ENVIRI CORP | 1.7M | $34.3M | 1.7% | $20.16 | 0.00% | 1 qtr | First report 0 |
ACI Worldwide Inc | 1M | $33.5M | 1.7% | $32.87 | 0.00% | 1 qtr | First report 0 |
CYBERARK SOFTWARE LTD | 274,157 | $32.6M | 1.6% | $119.05 | 0.00% | 1 qtr | First report 0 |
Hood River Capital Management LLC manages $2B across 105 positions as of Q1 2019. Top holdings: BEAT (3.0%), ELDORADO RESORTS INC (3.0%), SAGE (2.8%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2.5/5.0.
First quarter we have for this fund: 105 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $2.0B across 105 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR